Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,191,447 papers from all fields of science
Search
Sign In
Create Free Account
IMC1C11
Known as:
IMC-1C11
, IMC-1C11 Chimerized Monoclonal Antibody
A monoclonal antibody that selectively binds with KDR and blocks the vascular endothelial growth factor-induced endothelial cell proliferation and…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Antibodies
antigen binding
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
[Anti-angiogenesis targeting drugs: a review].
Ka Jia
,
Jin Li
Ai zheng = Aizheng = Chinese journal of cancer
2008
Corpus ID: 30998177
The dependence of tumor growth and metastasis on blood vessels makes tumor angiogenesis a rational target for cancer therapy. One…
Expand
2007
2007
Metronomic chemotherapy dosing-schedules with estramustine and temozolomide act synergistically with anti-VEGFR-2 antibody to cause inhibition of human umbilical venous endothelial cell growth
T. Lam
,
J. Hetherington
,
J. Greenman
,
Samantha Little
,
A. Maraveyas
Acta oncologica
2007
Corpus ID: 25812676
The effects of ‘metronomic'or extended chemotherapy dosing schedules (ECS) are mediated through poorly understood anti-angiogenic…
Expand
2003
2003
Gateways to clinical trials.
M. Bayés
,
X. Rabasseda
,
J. Prous
Methods and Findings in Experimental and Clinical…
2003
Corpus ID: 12836253
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the…
Expand
2003
2003
Gateways to clinical trials.
M. Bayés
,
X. Rabasseda
,
J. Prous
Methods and Findings in Experimental and Clinical…
2003
Corpus ID: 9049018
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the…
Expand
2001
2001
Technology evaluation: IMC-1C11, ImClone Systems.
S. Hunt
Current opinion in molecular therapeutics (Print)
2001
Corpus ID: 35624064
ImClone is developing IMC-IC11, an anti-angiogenesis chimeric monoclonal antibody specific vascular endothelial growth factor…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE